GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » Additional Paid-In Capital

Genflow Biosciences (LSE:GENF) Additional Paid-In Capital : £4.83 Mil(As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Additional Paid-In Capital?


Genflow Biosciences's quarterly additional paid-in capital increased from Dec. 2023 (£4.19 Mil) to Jun. 2024 (£4.84 Mil) but then stayed the same from Jun. 2024 (£4.84 Mil) to Dec. 2024 (£4.83 Mil).

Genflow Biosciences's annual additional paid-in capital stayed the same from Dec. 2022 (£4.19 Mil) to Dec. 2023 (£4.19 Mil) but then increased from Dec. 2023 (£4.19 Mil) to Dec. 2024 (£4.83 Mil).


Genflow Biosciences Additional Paid-In Capital Historical Data

The historical data trend for Genflow Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Additional Paid-In Capital Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
0.63 4.19 4.19 4.83

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial 4.19 4.19 4.19 4.84 4.83

Genflow Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Genflow Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process, and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines